Medicine and Dentistry
Systemic Scleroderma
100%
Scleroderma
80%
Pulmonary Hypertension
37%
Interstitial Lung Disease
21%
Disease
18%
Raynaud Phenomenon
12%
Malignant Neoplasm
10%
Biological Marker
8%
Placebo
8%
Autoantibodies
7%
Randomized Controlled Trial
6%
Lichen Myxedematosus
6%
Diagnosis
5%
Cyclophosphamide
5%
Vascular Disease
5%
Myositis
5%
Fibrosis
5%
Patient-Reported Outcome
5%
Keyphrases
Systemic Sclerosis
92%
Scleroderma
77%
Pulmonary Arterial Hypertension
19%
Pulmonary Hypertension
17%
Interstitial Lung Disease
16%
Autoantibodies
12%
Patient-centered Intervention
11%
Confidence Interval
11%
Diffuse Cutaneous Systemic Sclerosis
10%
Risk Factors
8%
Raynaud's Phenomenon
7%
Systemic Sclerosis-associated Pulmonary Arterial Hypertension
7%
Odds Ratio
7%
Forced Vital Capacity
5%
Hypertension Diagnosis
5%
Lenabasum
5%
Scleroderma Mimic
5%
Fibrosis
5%
Placebo
5%